ESTHER - EStrogen THromboEmbolism Risk ARCHIVE

Head :
Scarabin Pierre-Yves

Last update : 09/05/2017 | Version : 1 | ID : 5552

print
Print
xml
XML

Export to XML

Please choose the format :

pdf
PDF
xml
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection

Which version do you want to export ?

send
Send
General
Identification
Detailed name EStrogen THromboEmbolism Risk
Sign or acronym ESTHER
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation CNIL 999271, CCPPRB Brest 24 aout 1998, DGS 980433
General Aspects
Medical area Cardiology
Endocrinology and metabolism
Health determinants Iatrogenic
Others (details) Menopause hormone therapy
Keywords Menopause, hormone therapy, progesterone, oestrogen, progestin
Scientific investigator(s) (Contact)
Name of the director Scarabin
Surname Pierre-Yves
Address 16 Avenue Paul Vaillant Couturier, 94807 VILLEJUIF
Phone +33 (0)1 45 59 51 12
Email pierre-yves.scarabin@inserm.fr
Organization Institut National de la Santé et de la Recherche
Collaborations
Participation in projects, networks and consortia Yes
Funding
Funding status Mixed
Details - Fondation de France - Fondation pour la Recherche Médicale - Institut Nationale de la Santé et de la Recherche Médicale - Besins International - Sanofi
Governance of the database
Sponsor(s) or organisation(s) responsible Institut National de la Santé et de la Recherche Médicale
Organisation status Public
Additional contact
Main features
Type of database
Type of database Study databases
Study databases (details) Case control study
Database recruitment is carried out by an intermediary A selection of health institutions and services
A population file
Database recruitment is is made on the basis of: Medication(s) taken
Database recruitment is carried out as part of an interventional study No
Additional information regarding sample selection. Hospital and commuinity case subjects, hospital and community case-controls (randomly selected from electoral registers)
Database objective
Main objective To evaluate the risk of venous thromboembolism in connection with hormone therapy for menopause while considering the administration route for oestrogen and types of progestin.
Inclusion criteria - Women - between 45 and 65 years of age - menopausal - with no cardiovascular history or breast cancer
Population type
Age Adulthood (45 to 64 years)
Population covered Sick population
Gender Woman
Geography area National
Detail of the geography area France (multicentric hospital and general population study)
Data collection
Dates
Date of first collection (YYYY or MM/YYYY) 1999
Date of last collection (YYYY or MM/YYYY) 2003
Size of the database
Size of the database (number of individuals) [500-1000[ individuals
Details of the number of individuals 728 - 195 sujets atteints/cases - 533 témoins/controls
Data
Database activity Data collection completed
Type of data collected Clinical data
Declarative data
Clinical data (detail) Direct physical measures
Medical registration
Declarative data (detail) Face to face interview
Presence of a biobank Yes
Contents of biobank DNA
Details of biobank content DNA bank
Health parameters studied Health event/morbidity
Procedures
Data collection method Selection and questionnaire by dedicated CRA in each centre
Classifications used ----
Participant monitoring No
Links to administrative sources No
Promotion and access
Promotion
Link to the document http://www.ncbi.nlm.nih.gov/pubmed/12927428
Link to the document http://www.ncbi.nlm.nih.gov/pubmed/15978114
Link to the document http://www.ncbi.nlm.nih.gov/pubmed/16301339
Link to the document http://www.ncbi.nlm.nih.gov/pubmed/16409454
Link to the document http://www.ncbi.nlm.nih.gov/pubmed/16706969
Link to the document http://www.ncbi.nlm.nih.gov/pubmed/17309934
Link to the document http://www.ncbi.nlm.nih.gov/pubmed/18217166
Link to the document http://www.ncbi.nlm.nih.gov/pubmed/18495631
Link to the document http://www.ncbi.nlm.nih.gov/pubmed/18628519
Link to the document http://www.ncbi.nlm.nih.gov/pubmed/19320825
Link to the document http://www.ncbi.nlm.nih.gov/pubmed/19782484
Link to the document http://www.ncbi.nlm.nih.gov/pubmed/21107315
Link to the document http://www.ncbi.nlm.nih.gov/pubmed/12927428
Link to the document http://www.ncbi.nlm.nih.gov/pubmed/16409454
Link to the document http://www.ncbi.nlm.nih.gov/pubmed/16301339
Link to the document http://www.ncbi.nlm.nih.gov/pubmed/17309934
Link to the document http://www.ncbi.nlm.nih.gov/pubmed/18495631
Access
Terms of data access (charter for data provision, format of data, availability delay) Contact the scientist in charge
Access to aggregated data Access on specific project only
Access to individual data Access on specific project only

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05

View Edit Create here